|
Volumn 159, Issue 7, 2002, Pages 1146-1154
|
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety
a a a a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIPARKINSON AGENT;
HALOPERIDOL;
LITHIUM;
PLACEBO;
RISPERIDONE;
VALPROATE SEMISODIUM;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
EXTRAPYRAMIDAL SYMPTOM;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MANIA;
MANIC DEPRESSIVE PSYCHOSIS;
PRIORITY JOURNAL;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
AGED;
ANTIMANIC AGENTS;
ANTIPARKINSON AGENTS;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
BIPOLAR DISORDER;
BRIEF PSYCHIATRIC RATING SCALE;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
HALOPERIDOL;
HUMANS;
LITHIUM;
MALE;
MIDDLE AGED;
PLACEBOS;
PSYCHIATRIC STATUS RATING SCALES;
RISPERIDONE;
TREATMENT OUTCOME;
VALPROIC ACID;
|
EID: 0036307574
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.159.7.1146 Document Type: Article |
Times cited : (397)
|
References (41)
|